StockrabitBrowse analysts
Analyst questions

Jugal Shah

Firm not listed in source transcripts
MARKSANS

Marksans Pharma Limited

All company calls
FY2027 Q1
13 Aug 2026
Open call
  1. Hi Mark. Thanks for taking my question. I just want to go back to the question where one of the previous participants mentioned around the usage of cash component. So I see we have INR1,000 crores cash and the top line is INR3,000 crores. So that number sounds very conservative.

    Read in transcript
  2. That's good to know Mark, but just again, to add to that, I think we have reached a level, our platform is there, I'm sure we are very confident on the management team, but 15% to 20% growth seems to be very conservative where we are right now we kind of t ry to achieve more better 20%-25% growth should be the new normal given that where we are at this moment.

    Read in transcript
  3. Thank you, Mark.

    Read in transcript